Pfizer Inc. vs Target Corporation: Strategic Comparison
Key Differences at a Glance
| Field | Pfizer Inc. | Target Corporation |
|---|---|---|
| Revenue | $62.6B | $104.8B |
| Founded | 1849 | 1902 |
| Employees | 75,000 | 415,000 |
| Market Cap | $148.0B | $63.1B |
| Headquarters | United States | United States |
Quick Stats Comparison
| Metric | Pfizer Inc. | Target Corporation |
|---|---|---|
| Revenue | $62.6B | $104.8B |
| Founded | 1849 | 1902 |
| Headquarters | New York, New York | Minneapolis, Minnesota |
| Market Cap | $148.0B | $63.1B |
| Employees | 75,000 | 415,000 |
Pfizer Inc. Revenue vs Target Corporation Revenue — Year by Year
| Year | Pfizer Inc. | Target Corporation | Leader |
|---|---|---|---|
| 2026 | N/A | $104.8B | Target Corporation |
| 2025 | $62.6B | $106.6B | Target Corporation |
| 2024 | $63.6B | $107.4B | Target Corporation |
| 2023 | $59.6B | $109.1B | Target Corporation |
| 2022 | $101.2B | $106.0B | Target Corporation |
Business Model Breakdown
Overview: Pfizer Inc. vs Target Corporation
This in-depth comparison examines Pfizer Inc. and Target Corporation across revenue, market value, business model, competitive positioning, and long-term growth strategy. Whether you are researching Pfizer Inc. on its own, evaluating Target Corporation, or weighing the two companies side by side, the breakdown below highlights where each company leads and where the gap between Pfizer Inc. and Target Corporation is widest.
On the headline numbers, Pfizer Inc. reports annual revenue of $62.6B against $104.8B for Target Corporation, while their respective market capitalizations stand at $148.0B and $63.1B. Pfizer Inc. is headquartered in United States and Target Corporation operates from United States, and those different home markets shape how each company competes.
Pfizer Inc.: Pfizer has repeatedly reinvented itself around new therapeutic waves, from industrial fermentation and penicillin to Lipitor, vaccines, COVID products, and now oncology. The 2025 profile is not a pandemic windfall story; it is a large pharmaceutical company trying to rebuild a durable growth base.
Target Corporation: Target is a retailer whose value comes from making mass retail feel curated. The business is strongest when stores, digital channels, owned brands and fulfillment services reinforce one another.
Business Models: How Pfizer Inc. and Target Corporation Make Money
Pfizer Inc. and Target Corporation pursue distinct approaches to generating revenue, and understanding how each company operates is the foundation of any fair comparison between Pfizer Inc. and Target Corporation.
Pfizer Inc. business model: Pfizer makes money from patented prescription medicines, vaccines, oncology products, hospital therapies, rare disease products, collaborations, and global commercial distribution. Its economics depend on R&D success, regulatory approvals, patent protection, reimbursement, and lifecycle management.
Target Corporation business model: Target's model combines large-format stores, digital commerce, store-based fulfillment, owned brands, loyalty, same-day services and retail media. Stores are both shopping destinations and local fulfillment nodes.
Competitive Advantage: Pfizer Inc. vs Target Corporation
The durability of a company's moat often decides long-term winners. Here is how the competitive advantages of Pfizer Inc. stack up against those of Target Corporation.
Pfizer Inc. competitive advantage: Pfizer advantage is scale: global regulatory expertise, manufacturing capacity, clinical development experience, commercial infrastructure, vaccine capabilities, and the ability to acquire or partner for scientific platforms.
Target Corporation competitive advantage: Target's advantage is the mix of curated merchandise, owned brands, convenient stores, same-day fulfillment and a brand position between discount utility and design-led retail.
Growth Strategy: Where Pfizer Inc. and Target Corporation Are Headed
Future prospects matter as much as current results. The growth strategies below explain how Pfizer Inc. and Target Corporation each plan to expand from here.
Pfizer Inc. growth strategy: Pfizer growth strategy emphasizes oncology, vaccines, internal medicine, obesity and metabolic research, business development discipline, cost reduction, and global commercial execution. Chris Boshoff became Chief Scientific Officer and President, Research & Development effective January 1, 2025.
Target Corporation growth strategy: Target is focusing on merchandising authority, guest experience, technology acceleration, team and community strength, stores-as-hubs, same-day fulfillment, retail media and owned-brand renewal.
Financial Picture: Pfizer Inc. vs Target Corporation
A closer look at the financial trajectory of Pfizer Inc. and Target Corporation rounds out the comparison.
Pfizer Inc.: Pfizer reported $62.579 billion of FY2025 revenue, compared with $63.627 billion in FY2024 and $59.553 billion in FY2023. Net income was $7.771 billion in FY2025. Pfizer employed approximately 75,000 people worldwide as of December 31, 2025.
Target Corporation: Target reported FY2025 revenue of $104.780B and net income of $3.705B. Q1 FY2026 net sales increased 6.7%, with comparable sales up 5.6% and EPS of $1.71.
Company-Specific SWOT Notes
Pfizer Inc.
Pfizer has manufacturing, regulatory, clinical, and commercial infrastructure that few competitors can match globally.
Major products face loss of exclusivity and pricing pressure, requiring strong replacement revenue.
The Seagen acquisition gives Pfizer a larger oncology platform and ADC pipeline if clinical and commercial execution succeeds.
Medicare negotiation, generic competition, and failed pipeline readouts can compress revenue and margins.
Target Corporation
Target combines discount pricing with design, owned brands and a more curated shopping experience than many mass retailers.
Target's store network supports shopping, pickup, returns and same-day delivery from local inventory.
Target can be pressured by Walmart and Costco on value, Amazon on digital convenience and specialty retailers on category depth.
Roundel, Target Circle and owned brands create paths to higher-margin growth beyond ordinary merchandise sales.
If Target loses style and assortment credibility, traffic and margin recovery become harder.
Head-to-Head Scorecard
| Category | Winner | Why |
|---|---|---|
| Revenue Scale | Target Corporation | Target Corporation reports the larger revenue base ($104.8B), which serves as a core operational scale signal. |
| Profitability Potential | Comparable | Both organizations prioritize market penetration or are at equivalent reporting tiers. |
| Company Age | Pfizer Inc. | Founded in 1849 vs 1902. The earlier pioneer typically commands longer historical institutional legacy. |
| Innovation Moat | Target Corporation | Higher aggregate count of major acquisitions and key R&D releases indicates a more active technology absorption velocity. |
| Scale (Employees) | Target Corporation | A significantly larger reported workforce supports enhanced global distribution capability. |
| Market Cap | Pfizer Inc. | Higher public valuation denotes greater forward-looking investor conviction in earnings potential. |
| Future Outlook | Tied | Strategic auditing assesses that both maintain defensive leadership vectors within their core market clusters. |
Who Wins Each Category?
Target Corporation reports the larger revenue base ($104.8B), which serves as a core operational scale signal.
Both organizations prioritize market penetration or are at equivalent reporting tiers.
Founded in 1849 vs 1902. The earlier pioneer typically commands longer historical institutional legacy.
Higher aggregate count of major acquisitions and key R&D releases indicates a more active technology absorption velocity.
A significantly larger reported workforce supports enhanced global distribution capability.
Who Wins: Pfizer Inc. or Target Corporation?
Reviewed by Swet Parvadiya, May 2026 - Author Profile
Our analysts compile business strategy profiles from public financial filings, press releases, and analyst reports. Each profile is reviewed for accuracy before publication by our editorial desk and updated on a rolling basis.
Frequently Asked Questions: Pfizer Inc. vs Target Corporation
Is Pfizer Inc. better than Target Corporation?
Verdict: Between Pfizer Inc. and Target Corporation, Target Corporation is the stronger overall option based on higher annual revenue. The decision still depends on which factors matter most for your needs, but on the weight of the evidence above, Target Corporation comes out ahead in this Pfizer Inc. vs Target Corporation comparison.
Who earns more — Pfizer Inc. or Target Corporation?
Target Corporation earns more with $104.8B in annual revenue versus Pfizer Inc.'s $62.6B. Target Corporation leads on total revenue based on latest verified figures.
Which company has higher revenue — Pfizer Inc. or Target Corporation?
Pfizer Inc. reported $62.6B, while Target Corporation reported $104.8B. The revenue leader is Target Corporation based on latest verified figures.
Pfizer Inc. revenue vs Target Corporation revenue — which is higher?
Pfizer Inc. revenue: $62.6B. Target Corporation revenue: $62.6B. Target Corporation has the larger revenue base of the two companies.
Sources & References
- SEC EDGAR: Pfizer Inc. Annual Filings (10-K, 8-K)
- Pfizer Inc. Corporate Website
- Pfizer Inc. Annual Report 2025 - Revenue and Financial Data
- sec.gov
- investors.pfizer.com
- pfizer.com
- investors.pfizer.com
- SEC EDGAR: Target Corporation Annual Filings (10-K, 8-K)
- Target Corporation Corporate Website
- Target Corporation Annual Report 2026 - Revenue and Financial Data
- sec.gov
- corporate.target.com
- corporate.target.com
- corporate.target.com